A novel modular platform for adoptive T cell therapy combining bispecific antibodies with synthetic agonistic receptors. (March 2019) - Karches, C.H.; Benmebarek, M.; Schmidbauer, M.L.; Kurzay, M.; Klaus, R.; Lesch, S.; Cadilha, B.; Rataj, F.; Heise, C.; Geiger, M.; Murr, R.; Berg, J.vom; et al.